Skip to content

Clinical trials

Phase 3 Irritable Bowel Syndrome trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Irritable Bowel Syndrome Phase: Phase 3 Clear all

50 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20033
20042
20052
20062
20071
20082
20092
20102
20111
20123
20133
20143
20152
20164
20172
20181
20191
20202
20214
20222
20231
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed30
Terminated5
Withdrawn4
Recruiting4
Active, not recruiting2
Unknown status2
Not yet recruiting2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Menarini Group3
Astellas Pharma Inc2
Furiex Pharmaceuticals, Inc2
GlaxoSmithKline2
Universitair Ziekenhuis Brussel2
AbbVie1
Alizyme1
American University of Beirut Medical Center1
Assistance Publique - Hôpitaux de Paris1
Bausch Health Americas, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Irritable Bowel Syndrome50
Diarrhea8
Constipation7
Abdominal Pain5
Intestinal Diseases4
Colonic Diseases, Functional3
Fibromyalgia2
Anxiety Disorders1
Borderline Personality Disorder1
Burning Mouth Syndrome1

Trials

Showing 51 to 50 of 50. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.